These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19826105)

  • 1. Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.
    Gupta V; Patwardhan GA; Zhang QJ; Cabot MC; Jazwinski SM; Liu YY
    J Lipid Res; 2010 Apr; 51(4):866-74. PubMed ID: 19826105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo.
    Khiste SK; Hosain SB; Dong Y; Uddin MB; Roy KR; Hill RA; Liu Z; Liu YY
    Sci Rep; 2017 Jun; 7(1):2976. PubMed ID: 28592871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: Its role in survival of HeLa cells against ceramide.
    Honda T; Motoyoshi K; Kasahara J; Yamagata K; Takahashi H; Nakamura H; Murayama T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158817. PubMed ID: 32980536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.
    Liu YY; Patwardhan GA; Bhinge K; Gupta V; Gu X; Jazwinski SM
    Cancer Res; 2011 Mar; 71(6):2276-85. PubMed ID: 21278235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced UDP-glucose Levels Are Associated with P-glycoprotein Over-expression in L1210 Cells and Limit Glucosylceramide Synthase Activity.
    Turáková K; Pavlíková L; Messingerová L; Lakatoš B; Breier A; Sulová Z
    Anticancer Res; 2015 May; 35(5):2627-34. PubMed ID: 25964538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive measure of Golgi sphingolipid flux using NBD C
    Lee AH; Snider JM; Moorthi S; Coant N; Trayssac M; Canals D; Clarke CJ; Luberto C; Hannun YA
    J Lipid Res; 2024 Aug; 65(8):100584. PubMed ID: 38925252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WP1066, a small molecule inhibitor of the JAK/STAT3 pathway, inhibits ceramide glucosyltransferase activity.
    Tsurumaki H; Katano H; Sato K; Imai R; Niino S; Hirabayashi Y; Ichikawa S
    Biochem Biophys Res Commun; 2017 Sep; 491(2):265-270. PubMed ID: 28739255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.
    Liu YY; Hill RA; Li YT
    Adv Cancer Res; 2013; 117():59-89. PubMed ID: 23290777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer.
    Madigan JP; Robey RW; Poprawski JE; Huang H; Clarke CJ; Gottesman MM; Cabot MC; Rosenberg DW
    Exp Cell Res; 2020 Mar; 388(2):111860. PubMed ID: 31972222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence HPLC Analysis of the
    Roy KR; Khiste SK; Liu Z; Liu YY
    Bio Protoc; 2019 Jun; 9(12):e3269. PubMed ID: 33654788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
    J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
    Turzanski J; Grundy M; Shang S; Russell N; Pallis M
    Exp Hematol; 2005 Jan; 33(1):62-72. PubMed ID: 15661399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
    Watters RJ; Fox TE; Tan SF; Shanmugavelandy S; Choby JE; Broeg K; Liao J; Kester M; Cabot MC; Loughran TP; Liu X
    Leuk Lymphoma; 2013 Jun; 54(6):1288-96. PubMed ID: 23181473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide glycosylation potentiates cellular multidrug resistance.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.
    Jiang Y; DiVittore NA; Kaiser JM; Shanmugavelandy SS; Fritz JL; Heakal Y; Tagaram HR; Cheng H; Cabot MC; Staveley-O'Carroll KF; Tran MA; Fox TE; Barth BM; Kester M
    Cancer Biol Ther; 2011 Oct; 12(7):574-85. PubMed ID: 21795855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
    Chapman JV; Gouazé-Andersson V; Karimi R; Messner MC; Cabot MC
    Exp Cell Res; 2011 Jul; 317(12):1736-45. PubMed ID: 21396934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M; Apohan E; Baran Y
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells.
    Gutiérrez-Iglesias G; Hurtado Y; Palma-Lara I; López-Marure R
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):809-17. PubMed ID: 25113261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golgi staining by two fluorescent ceramide analogues in cultured fibroblasts requires metabolism.
    Pütz U; Schwarzmann G
    Eur J Cell Biol; 1995 Oct; 68(2):113-21. PubMed ID: 8575458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.